On ____________, 2008, you entered into an agreement with Pluristem Therapeutics Inc. (the “Company”) pursuant to which you were issued a warrant to purchase up to an _____________ shares of Common Stock with an exercise price of $1.00 per share...Warrant and Option Agreement • February 13th, 2009 • Pluristem Therapeutics Inc • Biological products, (no disgnostic substances)
This is to confirm that you have agreed that the Warrant and the Option will not be exercisable until May _, 2009. It is agreed that in the event that the Company’s announcement that it is initiating its first human clinical trials comes before May _, 2009, then the Notice Period will commence on May _, 2009.
